Sartorius Stedim Biotech SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0013154002
EUR
155.90
-7.2 (-4.41%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
761.50
772.20
705.70
745.00
744.60
751.30
655.40
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
761.50
772.20
705.70
745.00
744.60
751.30
655.40
Raw Material Cost
416.10
455.30
378.30
400.30
388.30
435.00
380.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
46.50
47.00
51.40
30.90
63.30
58.30
37.90
Selling and Distribution Expenses
163.40
170.20
157.60
167.00
166.50
174.00
155.70
Other Expenses
-0.81
-1.53
-2.13
0.12
-2.41
-2.12
-0.06
Total Expenditure (Excl Depreciation)
617.90
657.20
566.00
599.40
594.00
646.10
573.00
Operating Profit (PBDIT) excl Other Income
143.6
115
139.70000000000002
145.6
150.6
105.19999999999999
82.4
Other Income
22.10
79.80
-0.90
-22.00
28.20
42.90
-9.10
Operating Profit (PBDIT)
246.80
278.70
217.70
201.50
256.20
228.70
149.50
Interest
46.50
47.00
51.40
30.90
63.30
58.30
37.90
Exceptional Items
0.00
-70.00
0.00
0.00
0.00
-48.80
0.00
Gross Profit (PBDT)
345.40
316.90
327.40
344.70
356.30
316.30
275.40
Depreciation
81.10
83.90
78.90
77.90
77.40
80.60
76.20
Profit Before Tax
119.10
77.80
87.40
92.60
115.40
40.90
35.50
Tax
31.00
30.60
22.70
24.00
30.00
-5.40
9.20
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
88.10
47.30
64.20
68.60
85.60
45.60
25.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
88.10
47.30
64.20
68.60
85.60
45.60
25.50
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
-0.10
0.50
0.00
-0.20
0.70
0.80
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
88.10
47.20
64.70
68.60
85.40
46.30
26.30
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.2
0.2
0.2
0.2
0.2
0.2
0.2
Reserves
4,108.40
4,090.50
4,036.20
4,003.60
3,972.30
3,986.60
3,901.90
Earnings per share (EPS)
0.91
0.49
0.66
0.7
0.88
0.47
0.26
Diluted Earnings per share
0.91
0.49
0.66
0.7
0.88
0.47
0.26
Operating Profit Margin (Excl OI)
18.86%
14.89%
19.8%
19.54%
20.23%
14.0%
12.57%
Gross Profit Margin
26.29%
20.94%
23.57%
22.89%
25.89%
16.17%
17.04%
PAT Margin
11.57%
6.13%
9.1%
9.21%
11.5%
6.07%
3.89%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -1.39% vs 9.42% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 86.65% vs -27.05% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 12.97% vs -9.01% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -1.06% vs -8.56% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Sartorius Stedim Biotech SA With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
761.50
0
761.50
Other Operating Income
0.00
0.00
0.00
Total Operating income
761.50
0
761.50
Raw Material Cost
416.10
0
416.10
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
46.50
0
46.50
Selling and Distribution Expenses
163.40
0
163.40
Other Expenses
-0.81
0.00
-0.81
Total Expenditure (Excl Depreciation)
617.90
0
617.90
Operating Profit (PBDIT) excl Other Income
143.60
0.00
143.60
Other Income
22.10
0
22.10
Operating Profit (PBDIT)
246.80
0
246.80
Interest
46.50
0
46.50
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
345.40
0
345.40
Depreciation
81.10
0
81.10
Profit Before Tax
119.10
0
119.10
Tax
31.00
0
31.00
Provisions and contingencies
0
0
0.00
Profit After Tax
88.10
0
88.10
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
88.10
0
88.10
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
88.10
0
88.10
Equity Capital
0
0
0.00
Face Value
0.20
0
0.00
Reserves
4,108.40
0
4,108.40
Earnings per share (EPS)
0.91
0
0.91
Diluted Earnings per share
0.91
0
0.91
Operating Profit Margin (Excl OI)
18.86%
0%
0.00
18.86%
Gross Profit Margin
26.29%
0%
0.00
26.29%
PAT Margin
11.57%
0%
0.00
11.57%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 76.15 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -1.39% vs 9.42% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 2.27% vs 11.65% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.81 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 86.65% vs -27.05% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 3.16% vs 50.09% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.47 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 12.97% vs -9.01% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -1.45% vs 24.18% in Mar 2025

Quarterly - Interest
Interest 4.65 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -1.06% vs -8.56% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -26.54% vs 29.98% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.86%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025